Author:
Al-Kuraishy Hayder M.,Al-Gareeb Ali I.,Saad Hebatallah M.,Batiha Gaber El-Saber
Subject
Cell Biology,Biochemistry
Reference14 articles.
1. COVID-19 and phosphodiesterase enzyme type 5 inhibitors;Al-Kuraishy;J Microsc Ultrastruct,2020
2. Al-Kuraishy HM, Al-Gareeb AI, Al-Hussaniy HA, Al-Harcan NAH, Alexiou A, Batiha GE-S (2022a) Neutrophil extracellular traps (NETs) and COVID-19: a new frontiers for therapeutic modality. Int Immunopharmacol 104(6):108516
3. Al-Kuraishy HM, Batiha GE, Faidah H, Al-Gareeb AI, Saad HM, Simal-Gandara J (2022b) Pirfenidone and post-COVID-19 pulmonary fibrosis: invoked again for realistic goals. Inflammopharmacology 31:1
4. The potential role of growth differentiation factor 15 in COVID-19: a corollary subjective effect or not?;Babalghith;Diagnostics,2022
5. Hypertension and its management in COVID-19 patients: the assorted view;Batiha;Int J Cardiol Cardiovas Risk Prev,2021
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献